
Assessing Regeneron Pharmaceuticals: Insights From 26 Financial Analysts
26 analysts have shared their evaluations of Regeneron Pharmaceuticals REGN during the recent three months, expressing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings, revealing the shifting …